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Primary Involvement of NADPH Oxidase 4
in Hypoxia-Induced Generation of Reactive
Oxygen Species in Adipose-Derived Stem Cells
Ji Hye Kim,1,2 Seung-Yong Song,3 Sang Gyu Park,4 Sun U. Song,5 Ying Xia,6 and Jong-Hyuk Sung1,2
We have previously demonstrated that hypoxia stimulates adipose-derived stem cells (ASCs) through the gen-
eration of reactive oxygen species (ROS). However, the precise mechanism involved in the ROS generation by
ASCs is not well understood. We sought to investigate in this work: (1) which subtype of NADPH oxidase (Nox) is
primarily expressed in ASCs; (2) where Nox4 is localized in ASCs; and (3) whether silencing of Nox4 attenuates
hypoxia-enhanced function of ASC. We used 2¢,7¢-dichlorofluorescin diacetate (DCF-DA) as an indicator of ROS
generation and found that the fluorescence intensity of DCF-DA was significantly increased after hypoxia expo-
sure (2% oxygen). In addition, hypoxia enhanced the proliferation and migration of ASCs and upregulated the
mRNA expression of Oct4 and Rex1. Quantitative analysis of mRNA expression of Nox family in ASCs dem-
onstrated that Nox4 is primarily expressed in ASCs, while immunofluorescence assay showed that Nox4 is mainly
localized in the perinuclear region and overlaps with Mitotracker, a mitochondria marker. Silencing of Nox4 by
siRNA treatment downregulated the RNA and protein expression of Nox4, which significantly reduced the ROS
generation under hypoxia. In addition, Nox4 silencing significantly reduced the proliferation and migration of
ASCs and downregulated the mRNA expression of Oct4 and Rex1. Phosphorylation of platelet-derived growth
factor receptor-b, AKT, and ERK1/2 also diminished following Nox4 silencing. In a nutshell, these results suggest
that Nox4 is primarily expressed in ASCs and plays a pivotal role in the hypoxia-enhanced stimulation of ASCs.
Introduction
Adipose-derived stem cells (ASCs) offer a potentialsource for tissue repair and regeneration. We have re-
cently shown that ASCs and their secretomes have diverse
pharmacological effects on skin, for example, acceleration of
wound healing and hair growth [1–6]. Hypoxic culturing
stimulated ASCs and enhanced their regenerative potential,
which is beneficial for ASC therapy [7,8]. Culturing ASCs in a
hypoxic incubator (2% oxygen content) increases their pro-
liferation, migration, and secretion of growth factor [8,9]. In a
previous study, we investigated the key mediators and the
signal pathways involved in the stimulation of ASCs during
short-term hypoxia and found that reactive oxygen species
(ROS) play a key stimulatory role (ie, ROS scavenger attenu-
ated the stimulation). In addition, increased cellular ROS was
accompanied by the activation of platelet-derived growth
factor receptor (PDGFR), extracellular signal-regulated ki-
nases (ERK), and AKT (cellular homologue of the viral v-akt
oncogene product, also known as a protien kinase B, or PKB)
signal pathways [10].
ROS have a significant involvement in cellular apoptosis
and contribute to the pathophysiology of many degenerative
diseases [11,12]. However, recent studies suggest that low
level ROS could act as second messengers and activate cel-
lular processes necessary for normal physiological function-
ing [13–17]. Most noteworthy of these is the stimulatory
effect of ROS on stem cells physiology. Stem cells maintain a
high ROS status and are responsive to ROS donors [18,19].
Intracellular ROS can be generated directly by the nicotin-
amide adenine dinucleotide phosphate (NADPH) oxidase
enzymes (Nox) and by the passive production of mitochon-
dria [20–23]. These enzymes were initially described in the
phagocytes, as a part of their defense against pathogens by
generating a Nox-induced superoxide anion. In addition, the
generation of ROS by Nox activation was reported in some
nonphagocytotic cells as well [10,22–24]. In particular, Nox is
one of the major sources of ROS generation in stem/pro-
genitor cells and is activated by growth factors or hypoxia
[25–27].
ROS generated from Nox play an important role in redox
signaling linked to stem cell mobilization and proliferation
1Department of Applied Bioscience and 4Department of Biomedical Science, CHA University, Seoul, Korea.
2Stem Cell Research Laboratory, CHA Stem Cell Institute, Seoul, Korea.
3Department of Plastic & Reconstructive Surgery, Bundang CHA Medical Center, CHA University, Seongnam-si, Kyunggi-do, Korea.
5Clinical Research Center, Inha University College of Medicine, Incheon, Korea.
6The Vivian L. Smith Department of Neurosurgery, The University of Texas Medical School at Houston, Houston, Texas.
STEM CELLS AND DEVELOPMENT
Volume 21, Number 12, 2012
 Mary Ann Liebert, Inc.
DOI: 10.1089/scd.2011.0561
2212
[28–30]. Several homologues of gp91phox (also known as
Nox2), Nox1, Nox3, Nox4, and Nox5, as well as the dual
oxidases (Duox) 1 and 2, have been identified in a number of
different tissues [31–33]. Of them, Nox4 is predominantly
expressed in ASCs and functions as a switch between pro-
liferation and differentiation of ASCs [34]. Nox4 modulates
and generates ROS in insulin signaling and the expression of
Nox4 is downregulated in the adipogenic differentiation of
ASCs [35,36]. Although it has been known about the essen-
tial role of Nox4 in the adipogenic differentiation of ASCs,
the Nox4-mediated stimulatory effect on ASCs has not been
explored yet.
To clarify the important roles of ROS generation and the
underlying mechanism in ASC physiology, this article in-
vestigates the following questions: (1) Which subtype of Nox
is primarily expressed in ASCs? (2) Where is Nox4 localized
in ASCs? (3) Does Nox4 silencing affect hypoxia-enhanced
ASC functions? To answer these important questions, we
investigated the involvement of Nox4 in ROS generation
under hypoxia using small interfering RNA (siRNA) method
in addition to the measurement of the expression and local-
ization of Nox families in ASCs.
Materials and Methods
Cell culture and inhibition study
Sampling of human subcutaneous adipose tissue and
isolation of ASCs has been previously reported [1,5]. Char-
acterization of ASCs was performed by transdifferentiation
and analysis of cell surface markers using flow cytometry.
ASCs were grown in Minimum Essential Medium Alpha
medium (GIBCO, Invitrogen) with 10% fetal bovine serum
(GIBCO), 1% penicillin, and streptomycin (GIBCO) at 37C in
humidified normoxia (5% CO2) and hypoxia (5% CO2, 2%
O2, and balanced N2). For the inhibition study of ROS gen-
eration, 100mM N-acetyl-cysteine (NAC, ROS inhibitor;
Sigma-Aldrich) and 100 nM dibenziodolium chloride (DPI,
NADPH oxidase inhibitors; Sigma) were used in this study.
ROS generation assay
ROS production in ASCs was measured using 2¢,7¢-
dichlorofluorescin diacetate (DCF-DA, Molecular Probes).
ASCs (7 · 105 cells) were seeded in 100mm culture dishes.
Cells were pretreated with NAC and DPI for 30–60min and
incubated with DCF-DA (20mM) for 10min at 37C in the
dark. After 10-min incubation under hypoxia or normoxia,
fluorescence images of the cells were examined for detection
of ROS production in cells with a fluorescence microscope
(ECLIPSE E600, Nikon). In addition, fluorescence intensity of
DCF-DA was measured and calculated using flow cytometry
(Becon Dickinson).
Proliferation assay
ASCs were plated on a 48-well plate at a density of 5,000–
7,000 cells in complete media. After 24 h, the medium was
replaced with serum-free medium containing 1% penicillin
and streptomycin. Then, cells were incubated in normoxia
(20% O2, 5% CO2) or hypoxia (2% O2, 5% CO2, and balanced
N2) with or without chemical inhibitors for 72 h. After in-
cubation, the medium was removed and cell proliferation
was measured using CCK-8 assay kit (Dojindo). CCK-8 so-
lution (150 mL) was added to each well and incubated for 2 h.
Then the absorbance was measured at 450 nm using a mi-
croplate reader (TECAN, Grodig).
Migration assay
For migration assay, ASCs (5· 105 cells/well) were seeded
in 6-well plates with complete medium. The following day,
confluent ASCs were kept in serum-free medium for 12–24 h.
Then serum-starved ASCs were wounded using migration
micropipette tip and were incubated in hypoxia and nor-
moxia. Cell migration was determined by microscopic ex-
amination at 24 h after wounding. For evaluation of ASC
migration, 5 randomly selected points along each wound
were marked, and the horizontal distance of migrating cells
from the point of initial wound was measured.
RT-PCR and quantitative real-time PCR
Total cellular RNA was extracted with TRIzol reagent
(Invitrogen), followed by a reverse transcription with cDNA
synthesis kit (Promega). cDNA was synthesized from 1 mg
total RNA using 200U of reverse transcriptase (M-MLV RT)
and 50 ng/mL oligo(dT). The oligonucleotides used as prim-
ers are listed in Table 1. Polymerase chain reactions (PCRs)
were performed in a final volume of 25 mL reaction mixture
that contained 2mL of the reverse transcription (RT) reaction
mixture, 15mM MgCl2, 1.25mM dNTP, 20 pM of each pri-
mer, and 0.5U of Taq polymerase (Promega). Thermal cy-
cling over 40 cycles consisted of an initial denaturation at
94C for 5min, then 94C for 30 seconds, 56C for 30 s, and
72C for 30 s and was terminated by a final extension at 72C
for 5min. Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) mRNA level was used for sample standardization.
Quantitative real-time PCR (Q-PCR) reactions were per-
formed in exicycler 96 cycler (Bioneer) using Quiagen
QuantiTect SYBR green PCR kit. Evaluation of fold change
was calculated using DCt value.
Antibodies
Antibodies recognizing AKT (1:3,000), phospho-AKT
(1:2,000), ERK (1:3,000), phospho-ERK (1:3,000), PDGFR-b
(1:2,000) and phospho-PDGFR-b (Y1009, 1:1,000) were
purchased from Cell signaling Technology. Nox4 (1:1,000)
was purchase from Abcam. Horseradish-peroxidase (HRP)-
conjugated secondary mouse antibody (1:10,000) and HRP-
conjugated secondary rabbit antibody (1:10,000) were
purchased from Santa Cruz Biotechnology.
Western blotting
Proteins were solubilized using sodium dodecyl sulfate
(SDS) sampling buffer. Lysates were separated by 10% or 8%
SDS-PAGE and transferred to a PVDF membrane (Milli-
pore). The membrane was blocked with 5% skim milk for 1 h
at room temperature and then incubated overnight with
primary antibody at 4C. The following day, the membrane
was washed with TBS-T (0.1% Tween 20 in Tris-buffered
saline) and it was incubated with HRP-conjugated secondary
antibody for 1 h at room temperature. The membrane was
reacted to enhanced chemiluminescence solution (Millipore)
and exposed.
NOX4 INVOLVEMENT IN THE ROS GENERATION OF ASCS 2213
siRNA transfection
ASCs were seeded in 60-mm dishes with complete me-
dium without antibiotics. The following day, confluent ASCs
were kept in serum-free medium without antibiotics for 2 h.
Then, 50nM Nox4 siRNA was transfected with lipofectamine
2000 (Invitrogen). Three siRNA was obtained from Invitro-
gen with specific sequences (Nox4 siRNA-1: sense: 5¢-UUAU
CCAACAAUCUCCUGGUUCUCC-3¢; antisense: 5¢-GGAGA
ACCAGGAGAUUGUUGGAUAA-3¢, Nox4 siRNA-2: sense:
5¢-ACAGUGAAGACUUUGUUGAACUGAA-3¢; antisense:
5¢- UUCAGUUCAACAAAGUCUUCACUGU-3¢, Nox4 siRNA-
3: sense: 5¢-CCUCAUGAUCACAGCCUCUACAUAU-3¢;
antisense: 5¢-AUAUGUAGAGGCUGUGAUCAUGAGG-3¢).
Cells were incubated for 24 or 48 h after siRNA transfection.
The outcomes of Nox4 silencing were evaluated by RT-PCR
and western blot analysis of Nox4.
Immunostaining of Nox4 and mitochondria
ASCs were seeded on cover slips and incubated at 37C/
5% CO2 for 20min with 100 nM of Mitotracker or ER tracker
(Molecular Probes). After mitochondria staining, cells were
fixed with 3.7% paraformaldehyde for 15min. Primary anti-
body (Nox4) was diluted at 1:200, and secondary antibody
(FITC) at 1:400. Nuclear area was stained using 4¢,6-
diamidino-2-phenylindole (DAPI) (Sigma). Fluorescence
signals of different colors were detected by florescence
microcopy (ECLIPSE E600).
Fractionation of mitochondria
For fractionation of cytosol and mitochondria, ASCs were
seeded in 150-mm dishes at density of 1.5 · 107 cells. Cells
were harvested and Cytosol Extraction Buffer (BioVision)
was used to isolate proteins. After lysis, cells were homoge-
nized and centrifuged. Supernatant was collected for cytosolic
fraction. Then, the pellet was resuspended and the mito-
chondrial fraction was isolated using Mitochondrial Extrac-
tion Buffer (BioVision). Mitochondrial fractionation was
evaluated by western blot analysis using heat shock protein 60
(Hsp60, a mitochondria marker; Stressgen Biotechnology).
Statistical analysis
All data were representative of triplicate independent ex-
periments. The statistical significance of the differences
among various groups was tested using the analysis of
variance or student’s t-test. P < 0.05 or P< 0.01 were consid-
ered to be significant.
Results
ROS generation by hypoxia
Fluorescence images in Fig. 1A show that acute hyp-
oxia (2% O2 concentration for 10min) significantly in-
creased the signal intensity of DCF-DA in ASCs (green).
In contrast to normoxia, fluorescence intensity of ASCs
was significantly increased under hypoxia. In contrst, a
NAC (a scavenger of ROS, 100 mM concentration) and a
DPI (a Nox inhibitor, 100 nM concentration) significantly
reduced the signal intensity of DCF-DA in ASCs. In ad-
dition, ROS generation was confirmed and calculated
by flow cytometry, and the geometric mean of the fluo-
rescence intensity of DCF-DA was significantly increased
in hypoxia-incubated ASCs (Fig. 1B, P < 0.05). However,
staining of reactive nitrogen species (RNS) with 4,5-dia-
minofluorescein diacetate showed that acute hypoxia did
not change the generation of RNS levels in ASCs (Sup-
plementary Fig. S1; Supplementary Data are available
online at www.liebertonline.com/scd). This confirms that
oxygen species are primarily generated in response to
acute hypoxia in ASCs.
Hypoxia-enhanced proliferation and migration
Incubation of ASCs in hypoxia (2% O2) for 72 h signifi-
cantly increased the proliferation (Fig. 2A, P < 0.01) of ASCs,
which was in turn reduced after NAC and DPI treatment.
Likewise, hypoxia (2% O2 for 24 h) significantly increased
the migration of ASCs, but NAC or DPI treatment reduced
their migration (Fig. 2B, P < 0.01). These results suggest that
hypoxia-induced ROS plays a pivotal role in the stimulation
of ASCs.
Table 1. List of Primers for Polymerase Chain Reaction
Sequence
Target gene Forward Reverse
Nox1 5¢-GGCCTATATGATCTGCCTAC-3¢ 5¢-GAGATAGGCTGGAGAGAATG-3¢
Nox2 5¢-TGATGAGGAGAAAGATGTGA-3¢ 5¢-AGAGTTGGAGATGCTTTGTT-3¢
Nox3 5¢-TAGCTGTTAATGCAACCATC-3¢ 5¢-TTGTCCTTAGCAATTCAGTG-3¢
Nox4 5¢-CTTTTGGAAGTCCATTTGAG-3¢ 5¢-GTCTGTTCTCTTGCCAAAAC-3¢
Nox5 5¢-TAACATCAAGTGCTACATCG-3¢ 5¢-TGCCTGTACATGATACTCTG-3¢
Duox1 5¢-CGACATTGAGACTGAGTTGA-3¢ 5¢-CTGGAATGACGTTACCTTCT-3¢
Duox2 5¢-CTCTCTGGAGTGGTGGCCTATT-3¢ 5¢-GGACCTGCAGACACCTGTCT-3¢
Nanog 5¢-AATAACCTTGGCTGCCGTCTCT-3¢ 5¢-AGCAAAGCCTCCCAATCCCAAA-3¢
Sox2 5¢-GGGGAAAGTAGTTTGCTGCCTC-3¢ 5¢-CCGCCGCCGATGATTGTTATT-3¢
Klf4 5¢-GGGCAAGTTCGTGCTGAAGG-3¢ 5¢-GAAGAGACCGCCTCCTGCTT-3¢
c-myc 5¢-CTTGCCGCATCCACGAAACT-3¢ 5¢-TGCACCGAGTCGTAGTCGAG-3¢
Oct4 5¢-ACCTTCCAATGTGGAGCATC-3¢ 5¢-GAATTTGGCTGGAACTGCA-3¢
Rex1 5¢-GCTTCTTCCGGGCCATTGACTG-3¢ 5¢-TTGTAGGGGTCGTAACCCAGCC-3¢
Poldip2 5¢-CCCTGGAAAGCAATAAAGAT-3¢ 5¢-AAAGAACCCCACAATCAAAT-3¢
GAPDH 5¢-CGAGATCCCTCCAAAATCAA-3¢ 5¢-TGTGGTCATGAGTCCTTCCA-3¢
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Upregulation of Oct4 and Rex1 mRNA
In addition, mRNA expression of stemness-associated
genes was measured by RT-PCR at 4 h after hypoxia. Even
though the expression of Nanog, Sox2, Klf4, and c-Myc was
unaltered (Fig. 2C), that of Oct4 and Rex1 was significantly
increased by hypoxia and was diminished following NAC
and DPI treatment (Fig. 2D). Therefore, mRNA expression of
Oct4 and Rex1 was calculated by Q-PCR and significantly
upregulated. NAC and DPI showed inhibitory effects on
mRNA expression of Oct4 and Rex1 (Fig. 2E; Oct4, P < 0.01;
Rex1, P < 0.05).
Different expression of Nox family members
under hypoxia
NAC or DPI treatment reduced hypoxia-induced ROS
generation and disrupted ASC functioning, which suggests
the potential involvement of Nox family in ROS generation by
hypoxia. Therefore, the mRNA expression of Nox family in
ASCs was measured to clarify which is primarily involved in
ROS generation. Figure 3A shows that expression of Nox1-3
and Duox2 was negligible, while that of Nox4, Nox5, and
Duox1 was detected after amplification of cDNA for 40 cycles.
Relative expression of Nox4, Nox5, and Duox1 was measured
by Q-PCR. The data showed that Nox4 is predominantly ex-
pressed in ASCs (Fig. 3B). Because expression of Nox family
can be regulated by external stimuli such as hypoxia and in-
sulin treatment [35–37], we investigated whether hypoxia
modulates mRNA expression of Nox family. However, hyp-
oxia (2% O2 for 4 and 24h) did not change the mRNA ex-
pression of Nox4, Nox5, and Duox1 in ASCs (Fig. 3B).
Localization of Nox4
Immunofluorescence was used to detect the localization of
Nox4 in ASCs. Nox4 antibody was detected with FITC an-
tibody (green), and cellular organelles were counterstained
with DAPI (blue, a nuclear marker), ER-tracker (red, an en-
doplasmic reticulum marker), and Mitotracker (red, a mito-
chondria marker). As shown in Fig. 4A, a high intensity of
Nox4 signal was detected in perinuclear region and matched
well with Mitotracker (orange spots in merged picture).
However, Nox4 signal did not merge with ER-tracker (data
not shown). In addition, cell fractionation was performed
using a mitochondrial fractionation kit. Western blot analysis
showed that Nox4 is predominantly localized in the mito-
chondrial fraction, but was present in negligible amounts in
the cytosolic fraction (Fig. 4B). Our data suggest that Nox 4 is
primarily expressed in mitochondria of ASCs.
Decrease in hypoxia-induced ROS generation
due to silencing Nox4
Because Nox4 is primarily expressed in ASCs, and might
be a potential candidate of ROS generator, the involvement
FIG. 1. ROS generation by hypoxia. (A) The fluorescence microscopy images show that the signal intensity of DCF-DA in
ASCs (green) significantly increased under acute hypoxia (2% O2 concentration for 10min), which was attenuated by NAC (a
ROS scavenger, 100 mM concentration) and DPI (a Nox inhibitor, 100 nM concentration) treatment. (B) Relative value for
DCF-DA intensity was measured by flow cytometry. *P < 0.01. ASCs, adipose-derived stem cells; DCF-DA, 2¢,7¢-dichloro-
fluorescin diacetate; DPI, dibenziodolium chloride; NAC, N-acetyl-cysteine; Nox, NADPH oxidase; ROS, reactive oxygen
species.
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FIG. 2. ASC stimulation by
hypoxia. Hypoxia increased
the proliferation (A) and mi-
gration (B) of ASCs, which
was attenuated by NAC and
DPI treatment. In addition,
mRNA expression of stem-
ness-associated genes was
measured using RT-PCR at
4 h after hypoxia, but there
was no difference in Nanog,
Sox2, Klf4, and c-Myc (C).
However, mRNA expression
of Oct4 and Rex1 was sig-
nificantly upregulated and
attenuated by ROS inhibi-
tors (D). Relative mRNA
levels were measured and
calculated with Q-PCR
(E). *P< 0.05, **P < 0.01. RT-
PCR, reverse transcription–
polymerase chain reaction;
Q-PCR, quantitative real-time
PCR.
FIG. 3. Nox family expression in
ASCs. The mRNA expression of Nox
family (Nox1-5, Duox1, Doux2) was
measured by RT-PCR, and signals for
Nox4, Nox5, and Duox1 were detected
(A). Relative expression of Nox4,
Nox5, and Duox1 was measured using
Q-PCR, showing that Nox4 is primar-
ily expressed in ASCs. In addition,
Nox4, Nox5, and Duox1 expression
did not change under hypoxia (B).
Duox, dual oxidase.
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of Nox4 in ROS generation was further investigated using 3
different siRNAs forNox4. Transfection of siRNA (50nM each)
with lipofectamine significantly decreased the Nox4 mRNA
level as demonstrated by RT-PCR but did not affect Nox5 and
Duox1 (Fig. 5A). In addition, Nox4 protein expression was
significantly downregulated in western blot analysis (Fig. 5B).
ROS generation was measured by Facs analysis and signal
intensity for DCF-DA was significantly decreased by Nox4
siRNA transfection (Fig. 5C; first peak, negative control; second
peak, Nox4 siRNA treatment; third peak, negative siRNA). The
geometric mean of florescence intensity was measured and
found that three Nox4 siRNA treatments significantly reduced
the ROS generation (Fig. 5D, P< 0.01).
Attenuation of hypoxia-enhanced function
by Nox4 silencing
We further examined the involvement of Nox4 in hyp-
oxia-enhanced function of ASCs. As expected, Nox4
silencing by siRNA significantly decreased the hypoxia-
enhanced proliferation (Fig. 6A, P < 0.01) and migration
(Fig. 6B, P < 0.01) of ASCs. In addition, mRNA expression of
Oct4 and Rex1 was measured by Q-PCR and was seen to be
significantly decreased by siRNA transfection (Fig. 6C,
P < 0.01). These results indicate that Nox4-induced ROS
generation plays a significant role in the hypoxia-induced
stimulation of ASCs.
FIG. 4. Localization of Nox4 was
detected by immunofluorescence
method. (A) Nox4 signal (green)
was high in perinuclear region.
Mitochondria were counter-stained
with Mitotracker (red), nucleus with
DAPI (blue). Nox4 merged with
mitochondria (orange spots). (B) Cell
fractionation experiment has been
performed and was evaluated by
western blot analysis using Hsp60.
Nox4 was noted to be predomi-
nantly localized in the mitochon-
drial fraction but negligible in the
cytosolic fraction.
FIG. 5. Silencing of Nox4. Using 3
different siRNAs for Nox4, involve-
ment of Nox4 in ROS generation was
investigated. Transfection of siRNA for
Nox4 with lipofectamine significantly
decreased the Nox4 mRNA level in
RT-PCR (A) and the protein expression
in western blot analysis (B). ROS
generation was measured by Facs
analysis and signal intensity of DCF-
DA significantly decreased following
Nox4 silencing (C) (first peak, negative
control; second peak, Nox4 siRNA;
third peak, negative siRNA). Geo-
metric mean of fluorescence intensity
was measured and three kinds of Nox4
silencing significantly reduced the
ROS generation (D). ** P < 0.01.
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Signal pathways mediating Nox4 function
Previously it was shown that hypoxia-induced ROS acti-
vated/stimulated the PDGFR, AKT, and ERK-related signal
pathways [10]. Therefore, we investigated whether these
signal pathways are affected by the silencing of Nox4 en-
zyme. As shown in Fig. 6D, acute hypoxia (10min) increased
the phosphorylation of PDGFR-b, AKT, and ERK1/2 mole-
cules. However, Nox4 silencing by siRNA transfection sig-
nificantly reduced the hypoxia-enhanced phosphorylation of
PDGFR-b, AKT, and ERK1/2.
Discussion
Low oxygen tension (2–8% of O2) is an important char-
acteristic of the stem cell niche, and hypoxia provides an
adequate environment for the maintenance of stem cell
properties [38,39]. In addition, hypoxia enhances the
FIG. 6. Functional inhibition by Nox4 silencing. Nox4 silencing by siRNA significantly decreased the hypoxia-enhanced
proliferation (A) and migration (B) of ASCs. In addition, mRNA expression of Oct4 and Rex1 also diminished significantly
after Nox4 silencing (C). Nox4 silencing significantly attenuated the hypoxia-enhanced phosphorylation of PDGFR-b, AKT,
and ERK1/2 molecules (D). **P < 0.01. PDGFR, platelet-derived growth factor receptor
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proliferative and self-renewal capacities of mesenchymal
stem cells in vitro [40]. Suga et al. established surgically in-
duced ischemia models by disrupting blood supply, which
induced injury/death of cells including adipocytes, vascular
endothelial cells, and blood-derived cells. However, hypoxia
induced the proliferation of ASCs, indicating that hypoxia
also acts as a stimulator in vivo [39]. Although hypoxia is
considered to be beneficial for ASC maintenance, ASCs are
routinely cultured in normoxia (20% O2). As both hypoxia
and ROS generation stimulates the proliferation, migration,
and regenerative potential of ASCs under well-controlled
conditions, it could be beneficial to expose ASCs to hypoxia
during cell manipulation. In addition to the economic benefit
in cost reduction for ASC culture expansion, hypoxic pre-
conditioning is potentially beneficial for clinical application
owing to the enhancement of ASC regenerative capacity.
ROS are known to serve as a second messenger in the
intracellular signal transduction pathway for a variety of
cellular processes, including inflammation, cell cycle pro-
gression, apoptosis, aging, and cancer [29,41,42]. Although
excess accumulation of ROS exhibits adverse effects on the
cellular homeostasis, there is conflicting evidence that ROS at
low levels promote cell proliferation and survival [10,43,44].
Therefore, better understanding the complex role of ROS in
ASCs physiology is essential for clarify the key factors in-
volved in the dual aspects of ROS. It is likely that the de-
termining factor as to whether ROS is harmful or beneficial
to ASCs is primarily dependent on the concentration. The
low/moderate ROS generation may act as a stimulus for
ASC function. To test this hypothesis, we investigated the
effects of various ROS donors whether they stimulate or
damage ASCs. As expected, a low dose of antimycin (0.01–
10 mM concentration) significantly increased, while a higher
dose ( > 100 mM concentration) decreased, the proliferation
and migration of ASCs (our unpublished data). Likewise,
low dose rotenone (< 1 nM concentration) significantly in-
creased the proliferation and migration of ASCs. Therefore,
intracellular level of ROS is the key factor for ASC prolifer-
ation and migration of ASCs, which should be considered for
ASC maintenance.
Vascular endothelial growth factor (VEGF) stimulates
the growth of newly formed blood vessels and plays a role in
the tissue repair system by restoring the oxygen supply to the
tissues. In addition, VEGF acts as a key paracrine mediator of
ASC function and an increased VEGF secretion is closely
correlated with enhanced paracrine effect of ASCs. Interest-
ingly, VEGF expression is regulated by ROS generation
[10,45]. For example, hypoxia markedly increases the VEGF
mRNA level, which was attenuated by the ROS scavenging
and the inhibition of NADPH oxidase (Supplementary Fig.
S2A, B). In addition, lovastatin inhibited ROS generation by
Nox4 enzyme and downregulated VEGF expression [45].
Therefore, we investigated whether Nox4 affected VEGF ex-
pression in ASCs and found that Nox4 silencing reduced the
mRNA expression of VEGF (Supplementary Fig. S2C). These
results suggest that Nox4 is involved in the upregulation of
VEGF and may modulate the paracrine effects of ASCs.
There exists a controversial view on the subcellular local-
ization of Nox4 [46–48]. Chen et al. detected the Nox4 ex-
pression in endoplasmic reticulum (ER) of endothelial cells
and insisted that ER localization of Nox4 is critical for the
regulation of protein tyrosine phosphatase 1B [46]. However,
Nox4 signal did not match with ER marker in ASCs in our
study (data not shown), indicating that Nox4 is not highly
expressed in ER. Instead, Block et al. generated specific Nox4
antibody and reported that Nox 4 is highly expressed in
mitochondria of kidney cells using immunoblot anlysis and
immunofluorescence assay [48]. They merged Nox4 signal
with an ER marker and a Golgi marker, but the Nox4 signal
did not match with these organelles. Graham et al. also re-
ported that Nox4 is overexpressed in breast cancer cell lines
and is mainly localized in the mitochondria [47]. Our im-
munofluorescence data (Fig. 4) provides evidence that a
functional Nox4 is largely localized to and regulated by mi-
tochondria in ASCs. Therefore, this organelle may be an im-
portant source of ROS.
We have previously demonstrated that hypoxia stimu-
lates ASCs through ROS generation [10]. However, the
precise mechanism involved in the ROS synthesis of ASCs
has not yet been established. Therefore, we looked for the
specific subtype of Nox that is primarily expressed and
localized in ASCs, and whether Nox4 silencing affected
hypoxia-enhanced ASC functions. Quantitative analysis of
Nox family in ASCs demonstrated the predominant Nox4
expression. Immunofluorescence showed that Nox4 is
highly localized in the perinuclear region, especially in
mitochondria. Nox4 silencing reduced the generation of
ROS, notably reduced the proliferation/migration of ASCs,
and downregulated the mRNA expression of Oct4 and
Rex1. Phosphorylation of PDGFR-b, AKT, and ERK1/2 was
reduced by Nox4 silencing. Collectively, these results es-
pouse that Nox4 is primarily involved in the hypoxia-
enhanced stimulation of ASCs.
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